H. Pylori Infection: Improving Diagnostic Accuracy and Clinical OutcomesÂ
Diagnostic tests for an H. pylori infection can be invasive or noninvasive. Noninvasive testing is more cost-effective.
Diagnostic tests for an H. pylori infection can be invasive or noninvasive. Noninvasive testing is more cost-effective.
This rapidly emerging bacterial infection needs new diagnostics.
A report from the Howard Hughes Medical Institute explores the need for—and barriers to—laboratory testing for SARS-CoV-2.
Siemens’ total antibody test for covid-19 has been shown to have 100% sensitivity and 99.8% specificity for identifying antibodies to SARS-CoV-2.
Read MoreSema4 will provide covid-19 viral and antibody testing for state employees, first responders, long-term care facilities, and primary-care facilities.
Read MoreThe guidelines address the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2.
Read MoreThe Dallas-based pathology practice now has the ability to provide the covid-19 antibody test to medical practice providers across the country,
Read MoreThe company’s antibody test for covid-19 has received the CE mark; validation data demonstrated 100% sensitivity and 99.85% specificity.
Read MoreNephron will integrate its testing capabilities with One Medical’s technology platform, which can support a comprehensive workplace reentry testing program.
Read MoreThe PreTrm test provides an early and individual risk prediction for preterm birth in asymptomatic, singleton pregnancies.
Read MoreThe new assay permits the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum, and is designed to provide accurate results in a clinical laboratory setting with low- to high-throughput processing of specimens.
Read MoreThe S1-S2 chimeric glycoprotein has demonstrated excellent reactivity in ELISAs for the detection of IgA, IgG, and IgM antibodies against SARS-CoV-2.
Read MoreThe kits include a collection system and sample processing and molecular analytic components that circumvent supply shortfalls affecting the lab community.
Read MoreNew service provides employers with access to covid-19 testing, including fingerstick antibody blood testing.
Read MoreThe new immunological assay for covid-19 joins the lab’s molecular diagnostic, released in March to detect SARS-CoV-2 viral RNA in respiratory swab specimens.
Read MoreThe new data evaluate the performance of Grail’s multicancer blood test in symptomatic participants with suspicion of cancer.
Read MoreGenalyte currently has the capacity to test 250,000 patients per month; the company is scaling up to test more than 7,500,000 patients per month by September.
Read MoreLaboratory capacity for covid-19 antibody testing is expected to expand to approximately 150,000 tests per day by early May.
Read More